Developing specialized therapies to protect the immune system from chemotherapy and radiation damage.

Myelo Therapeutics is a pharmaceutical company, that is developing innovative treatments in areas of high unmet medical needs, such as Chemotherapy-induced Myelosuppression (CIM), Radiation-induced Myelosuppression (RIM), and Acute Radiation Syndrome (ARS). Exit: 2020, acquired by Eckert & Ziegler AG.